Evotec to attend upcoming investor conferences

On Septemner 6, 2019 Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) reported that its management will be presenting at and attending the following upcoming conferences (Press release, Evotec, SEP 6, 2019, View Source;announcements/press-releases/p/evotec-to-attend-upcoming-investor-conferences-5845 [SID1234539355]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

J.P. Morgan Cazenove Pan-European Small/Mid Cap Conference, London, UK

Date: Wednesday, 11 September 2019
Venue: London, UK
Attendee: Enno Spillner, Chief Financial Officer

Bank of America Merrill Lynch Global Healthcare Conference 2019, London, UK

Date: Wednesday, 18 September 2019,
Presentation: 18 September 2019, 4.25 pm BST
Venue: London, UK
Attendee: Werner Lanthaler, Chief Executive Officer

Baader Investment Conference, Munich, Germany

Date: Monday, 23 September 2019,
Presentation: 23 September 2019, 5.15 pm CEST
Venue: Munich, Germany
Attendee: Enno Spillner, Chief Financial Officer

Berenberg and Goldman Sachs Eighth German Corporate Conference, Munich, Germany

Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 2.30 pm CEST
Venue: Munich, Germany
Attendee: Enno Spillner, Chief Financial Officer

Ladenburg Thalmann Healthcare Conference, New York, NY, USA

Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 10.30 am EDT
Venue: New York, NY, USA
Attendee: Dr Werner Lanthaler, Chief Executive Officer

2019 Cantor Global Healthcare Conference, New York, NY, USA

Date: Wednesday, 02 October 2019,
Presentation: 02 October 2019, 3.00 pm EDT
Venue: New York, NY, USA
Attendee: Dr Werner Lanthaler, Chief Executive Officer